Results 191 to 200 of about 23,244 (239)
Some of the next articles are maybe not open access.
SCGN and STAT3 expressions are associated with the prognosis of ccRCC
Pathology Research and Practice, 2023Clear cell renal cell carcinoma (ccRCC) is highly heterogeneous and accounts for about 70% of RCC. Its prognosis is worse than that of most histological types of RCC. In order to find potential biomarkers that may influence the prognosis and survival in ccRCC patients, we explored the expressions of STAT3, PDL1 and SCGN (secretagogin) in ccRCC based on
Dandan Zhang, Maode Lai, Chong Lai
exaly +3 more sources
Urologic Oncology: Seminars and Original Investigations, 2016
Clear cell renal cell carcinoma (ccRCC) is the third most common urological cancer after prostate and bladder cancer but has the highest rate of mortality affecting over 40% of patients. microRNAs (miRNAs) are small noncoding RNAs that have become potential biomarkers and molecular targets for cancer treatment. Molecular markers such as miRNAs may have
Kristof Harda +2 more
exaly +3 more sources
Clear cell renal cell carcinoma (ccRCC) is the third most common urological cancer after prostate and bladder cancer but has the highest rate of mortality affecting over 40% of patients. microRNAs (miRNAs) are small noncoding RNAs that have become potential biomarkers and molecular targets for cancer treatment. Molecular markers such as miRNAs may have
Kristof Harda +2 more
exaly +3 more sources